(a) if it is sold, or offered or exhibited for sale, under a name which belongs to another drug; or
(b) if it is an imitation of, or is substitute for, another drug or resembles another drug in a manner likely to deceive, or bears upon it or upon its label or container the name of another drug, unless it is plainly and conspicuously marked so as to reveal its true chara cter and its lack of identity with such other drug; or
(c) if the label or container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist; or
(d) if it has been substituted wholly or in part by any other drug or substance; or
(e) if it purports to be the product of a manufacturer of whom it is not truly a product.]
Source footnotes
1. Subs. by s. 31, ibid., for sections.33D and 33E (w.e.f. 1-2-1983).आगे पढ़ें / Continue reading
Explore the next section or browse this act in the selected language.
More sections of this act
Section 1 · Short title, extent and commencement.Section 2 · Application of other laws not barred.Section 3 · Definitions.Section 3A · Construction of references to any law not in force or any functionary not in existence in the State of Jammu and Kashmir.Section 4 · Presumption as to poisonous substances.Section 5 · The Drugs Technical Advisory Board.Section 6 · The Central Drugs Laboratory.Section 7 · The Drugs Consultative Committee.India Code, Government of India. Text fetched 22 Oct 2026. Check the linked official text and subsequent notifications when applying a provision.